Inventor · disambiguated record
Xiao Hu
Also filed as: HU XIAO · HU XIAO SHELLEY
8 granted patents·3 pending applications·54 citations·filing 2008–2023
87Inventor score
Top patents by PatentIndex Score
11 records- 0194US9394315B2Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2013·Granted Jul 19, 2016·15 cites·30 claims
- 0292US9802958B2Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of diseaseLYCERA CORP·Filed 2016·Granted Oct 31, 2017·7 cites·25 claims
- 0391US10208061B2Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2017·Granted Feb 19, 2019·6 cites·19 claims
- 0490US7598231B2Tricyclic compound, compositions, and methodsPFIZER·Filed 2008·Granted Oct 6, 2009·13 cites·6 claims
- 0584US7786097B2Tricyclic compounds, compositions and methodsPFIZER·Filed 2009·Granted Aug 31, 2010·5 cites·8 claims
- 0683US8158660B2Tricyclic compounds, compositions and methodsCHENG HENGMIAO·Filed 2009·Granted Apr 17, 2012·4 cites·8 claims
- 0778US8445520B2Tricyclic compounds, compositions, and methodsCHENG HENGMIAO·Filed 2011·Granted May 21, 2013·2 cites·9 claims
- 0873US10532088B2Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methodsLYCERA CORP·Filed 2015·Granted Jan 14, 2020·2 cites·37 claims
- 0962US2014142316A1Tricyclic Compounds, Compositions, And MethodsPFIZER·Filed 2013·Application pending·0 cites
- 1061US2025197857A1Oligonucleotide compositions and methods thereof for exon skippingWAVE LIFE SCIENCES LTD·Filed 2023·Application pending·0 cites
- 1142US2020261463A1Treatment of cancer using aryl dihydro-2h-benzo[b][1,4]oxazine sulfonamide compoundsLYCERA CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiao Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →